Article

Estradiol-mediated endothelial nitric oxide synthase association with heat shock protein 90 requires adenosine monophosphate-dependent protein kinase

Boston University, Boston, Massachusetts, United States
Circulation (Impact Factor: 14.95). 07/2005; 111(25):3473-80. DOI: 10.1161/CIRCULATIONAHA.105.546812
Source: PubMed

ABSTRACT Estradiol activates endothelial nitric oxide synthase (eNOS) by mechanisms that involve estrogen receptor-alpha (ERalpha), protein kinase B/Akt, mitogen-activated protein kinases, and heat shock protein 90 (HSP90). Recently, AMP-activated protein kinase (AMPK), an enzyme that plays a crucial role in cellular adaptation to metabolic stress, has been implicated in physiological eNOS activation by the hormones adiponectin and insulin. We therefore investigated whether AMPK is activated by estradiol in endothelial cells and plays a role in estradiol-induced eNOS activation.
Porcine aortic endothelial cells exhibited time- and concentration-dependent AMPK activation as determined by phosphorylation of AMPK and its downstream target acetyl coenzyme A carboxylase in response to estradiol (1 nmol/L to 10 micromol/L, 1 to 30 minutes). AMPK activation by estradiol was independent of both AMP levels and ERalpha but required estradiol conversion to its catechol metabolites. Estradiol treatment increased eNOS catalytic activity, an effect that was largely reversed when endothelial cells were infected with an AMPK dominant-negative adenovirus. However, inhibition of AMPK did not alter estradiol-induced eNOS phosphorylation at serine 1177 or threonine 495 but decreased eNOS interaction with HSP90. Consistent with this observation, blood vessels from alpha1-AMPK-null mice exhibited defective eNOS-mediated NO production in response to estradiol.
Taken together, these data indicate that AMPK activity is essential for estradiol-induced eNOS activation via the promotion of eNOS interaction with HSP90. These data point to a novel role for AMPK in modulating endothelial cell NO bioactivity and HSP90 function.

Download full-text

Full-text

Available from: Elad Anter, Aug 03, 2015
0 Followers
 · 
76 Views
  • Source
    • "These data revealed that WSC induced AMPK Thr 172 dephosphorylation, thereby inactivating the AMPK enzyme. Moreover, there is abundant data showing the critical role of AMPK in endothelium-dependent vasodilatory function through modulating endothelial cell nitric oxide synthase (eNOS) activation and thus nitric oxide (NO) bioactivity (Schulz et al., 2005). AMPK and eNOS are essential mediators of NO-induced endothelial function and thus the effect of WSC on eNOS protein levels in HAEC cells was determined. "
    [Show abstract] [Hide abstract]
    ABSTRACT: AIM: Despite its increasing popularity, little is known about the health effects of waterpipe smoking (WPS), particularly on the cardiovascular system. To investigate the role of WPS as a risk factor for vascular disease, we evaluated its effect on endothelial cell function, which is an early event in vascular disease pathogenesis. We assessed the changes in cell viability, ROS generation, inflammatory and vasodilatory markers and in vitro angiogenesis of human aortic endothelial cells in response to waterpipe smoke condensate exposure. METHODS AND RESULTS: Mainstream waterpipe smoke condensate (WSC) was generated using a standard laboratory machine protocol. Compared to control, WSC induced cell cycle arrest, apoptosis, and oxidative stress in human primary endothelial cells. In addition, we assayed for impaired endothelium-dependent vasodilation and induced inflammation by studying the effect of WPS on the content and activity of AMPK, eNOS proteins and NF-kB p65 ser536 phosphorylation, respectively. WSC inhibited AMPK/eNOS phosphorylation and induced phosphorylation of p65. Moreover, we evaluated endothelial cells repair mechanism related properties that include migration/invasion and in vitro tube formation upon treatment with WSC. WSC reduced the motility and inhibited angiogenic potential of HAEC cells. CONCLUSIONS: WPS induced endothelial cell dysfunction as evident by exerting oxidative stress, inflammation, and impaired endothelial vasodilatory function and repair mechanisms. All together these data provide evidence for the potential contribution of WPS to endothelial dysfunction and thus to vascular disease.
    Toxicology Letters 02/2013; 219(2). DOI:10.1016/j.toxlet.2013.02.015 · 3.36 Impact Factor
  • Source
    • "Phosphorylation of eNOS at Ser1177 is pivotal in the direct regulation of superoxide versus NO generation, altering both the calcium sensitivity of the enzyme and the rate of reaction product formation [20]. In detail, direct phosphorylation of Ser1177 by adenine monophosphate kinase (AMPK) enhances eNOS activity by promoting its association with heat shock protein 90 [21]. This is also true for the uncoupled eNOS, for which Akt-mediated phosphorylation of Ser1177 markedly enhances maximal superoxide generation at low levels of calcium, making NO generation largely calcium independent [19]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The homodimeric flavohemeprotein endothelial nitric oxide synthase (eNOS) oxidizes l-arginine to l-citrulline and nitric oxide (NO), which acutely vasodilates blood vessels and inhibits platelet aggregation. Chronically, eNOS has a major role in the regulation of blood pressure and prevention of atherosclerosis by decreasing leukocyte adhesion and smooth muscle proliferation. However, a disturbed vascular redox balance results in eNOS damage and uncoupling of oxygen activation from l-arginine conversion. Uncoupled eNOS monomerizes and generates reactive oxygen species (ROS) rather than NO. Indeed, eNOS uncoupling has been suggested as one of the main pathomechanisms in a broad range of cardiovascular and pulmonary disorders such as atherosclerosis, ventricular remodeling, and pulmonary hypertension. Therefore, modulating uncoupled eNOS, in particular eNOS-dependent ROS generation, is an attractive therapeutic approach to preventing and/or treating cardiopulmonary disorders, including protective effects during cardiothoracic surgery. This review provides a comprehensive overview of the pathogenetic role of uncoupled eNOS in both cardiovascular and pulmonary disorders. In addition, the related therapeutic possibilities such as supplementation with the eNOS substrate l-arginine, volatile NO, and direct NO donors as well as eNOS modulators such as the eNOS cofactor tetrahydrobiopterin and folic acid are discussed in detail.
    Free Radical Biology and Medicine 04/2011; 50(7):765-76. DOI:10.1016/j.freeradbiomed.2010.12.018 · 5.71 Impact Factor
  • Source
    • "However, the increase of the AMPK activation state induced by 17-b estradiol treatment seems to be sufficient to phosphorylate HMGR and to restore its proper activity. The enhancement of estradiol-induced AMPK activation is supported also by other data in the literature (Schulz et al., 2005). Our results demonstrate that the estradiol decrease occurring at the onset of estropause does not affect the long-term regulation of HMGR, but rather its short-term modulation via AMPK activationstate control. "
    [Show abstract] [Hide abstract]
    ABSTRACT: a b s t r a c t Coronary heart disease is less prevalent in pre-menopausal women than in men, but increases at the onset of menopause. This delay is due to estrogen protective effects. The rise of cholesterolemia is one of the main risk factors for coronary disease. Since 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) is the rate-limiting enzyme of the cholesterol biosynthetic pathway, it plays a pivotal role in cho-lesterol homeostasis maintenance. Aim of this study is to investigate whether HMGR is involved in the cholesterolemia increase that occurs during aging, and to consider its potential role as a target for estro-gen protective effects. ''In vivo" studies have been performed using the livers of 12-month-old female rats (whose estrogen level decrease is comparable to the one detected at the occurrence of human meno-pause), 12-month-old female rats treated with 17-b-estradiol, and 3-month-old untreated male and female rats. The results indicated hypercholesterolemic status and a significant increase of HMGR activity according to a reduced activation of AMPK detected in treated rats compared to controls. Furthermore, 17-b estradiol treatment reduced HMGR activity restoring AMPK activation. These findings highlight the correlation between estrogen and HMGR short-term regulation, and suggest the presence of another mechanism underlying the protective role of estrogen in age-related diseases.
Show more